Pharma Cloud Services Key Players-Business, Deal & Patent Strategies

Latest Updates of Companies in the Pharma Cloud Services Market

Recent Developments in the Pharma Cloud Services Market

• In April 2026, Merck, known as MSD outside of the United States and Canada, and Google Cloud announced a landmark collaboration to improve Merck’s digital backbone as an AI-based enterprise.
• In March 2026, CVS Health and Google Cloud announced a novel strategic partnership that aims to reimagine health care experiences, increase consumer engagement, and eventually help to achieve better health results.
• In November 2025, GE HealthCare announced it had agreed to acquire Intelerad, a leading healthcare imaging software provider for the healthcare sector, for a purchase price of $2.3 billion paid in cash.

Supply Chain Analysis  

R&D:

• Research and development (R&D) in pharma cloud services includes drug discovery and preclinical services, clinical trial management and development, data management and digital infrastructure, regulatory and compliance services, and progressive analytics and modeling.
• Key Players: Amazon Web Services and Microsoft Azure

Manufacturing Processes:

• Manufacturing processes include production planning & execution, quality control and assurance, inventory and supply chain management, advanced production technologies, and regulatory compliance and documentation.
• Key Players: Accenture and IBM

Patient Services:

• Patient services programs (PSPs) in pharma cloud services are intended to enhance patient results, improve adherence to treatment regimens, and increase access to therapies, specifically for chronic or specialty conditions.
• Key Players: AstraZeneca and Sanofi

Market Growth

The global pharma cloud services market size was estimated at USD 10.86 billion in 2025 and is predicted to increase from USD 12.47 billion in 2026 to approximately USD 43.18 billion by 2035, expanding at a CAGR of 14.8% from 2026 to 2035.